444 related articles for article (PubMed ID: 15687886)
1. Colon cancer screening strategies.
Agrawal J; Syngal S
Curr Opin Gastroenterol; 2005 Jan; 21(1):59-63. PubMed ID: 15687886
[TBL] [Abstract][Full Text] [Related]
2. Stool test for colorectal cancer screening--it's time to move!
Loitsch SM; Shastri Y; Stein J
Clin Lab; 2008; 54(11-12):473-84. PubMed ID: 19216253
[TBL] [Abstract][Full Text] [Related]
3. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
Quintero E
Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
[TBL] [Abstract][Full Text] [Related]
4. Fecal occult blood testing: clinical value and limitations.
Simon JB
Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive testing for colorectal cancer: a review.
Ouyang DL; Chen JJ; Getzenberg RH; Schoen RE
Am J Gastroenterol; 2005 Jun; 100(6):1393-403. PubMed ID: 15929776
[TBL] [Abstract][Full Text] [Related]
6. Faecal screening of colorectal cancer.
Loganayagam A
Int J Clin Pract; 2008 Mar; 62(3):454-9. PubMed ID: 17887994
[TBL] [Abstract][Full Text] [Related]
7. The evolution to stool DNA testing for colorectal cancer.
Tagore KS; Levin TR; Lawson MJ
Aliment Pharmacol Ther; 2004 Jun; 19(12):1225-33. PubMed ID: 15191503
[TBL] [Abstract][Full Text] [Related]
8. New stool screening tests for colorectal cancer.
Young GP; Cole S
Digestion; 2007; 76(1):26-33. PubMed ID: 17947816
[TBL] [Abstract][Full Text] [Related]
9. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
10. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.
Greenberg PD; Bertario L; Gnauck R; Kronborg O; Hardcastle JD; Epstein MS; Sadowski D; Sudduth R; Zuckerman GR; Rockey DC
Am J Gastroenterol; 2000 May; 95(5):1331-8. PubMed ID: 10811348
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
[TBL] [Abstract][Full Text] [Related]
12. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
Sharma VK; Corder FA; Fancher J; Howden CW
Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Smith A; Young GP; Cole SR; Bampton P
Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
[TBL] [Abstract][Full Text] [Related]
14. Stool test for colorectal cancer screening: what is going on?
Bonanno E; Rulli F; Galatà G; Pucci S; Sesti F; Farinon AM; Spagnoli LG
Surg Oncol; 2007 Dec; 16 Suppl 1():S43-5. PubMed ID: 18055195
[TBL] [Abstract][Full Text] [Related]
15. A comparison of three stool tests for colorectal cancer screening.
Greenwald B
Medsurg Nurs; 2005 Oct; 14(5):292-9; quiz 300. PubMed ID: 16318108
[TBL] [Abstract][Full Text] [Related]
16. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
[TBL] [Abstract][Full Text] [Related]
17. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report.
Young GP; St John DJ; Winawer SJ; Rozen P;
Am J Gastroenterol; 2002 Oct; 97(10):2499-507. PubMed ID: 12385430
[TBL] [Abstract][Full Text] [Related]
18. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
19. Stool-based DNA tests for colorectal cancer: clinical potential and early results.
Ahlquist DA
Rev Gastroenterol Disord; 2002; 2 Suppl 1():S20-6. PubMed ID: 12439395
[TBL] [Abstract][Full Text] [Related]
20. Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.
Karl J; Wild N; Tacke M; Andres H; Garczarek U; Rollinger W; Zolg W
Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1122-8. PubMed ID: 18928937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
